Eliquis Internal Bleeding Lawsuit in NY

Yes. Under New York law, you may be able to bring a product liability claim against Bristol-Myers Squibb and Pfizer if Eliquis caused serious internal bleeding. These cases typically allege that the manufacturers failed to adequately warn patients and prescribers about the risk of uncontrollable hemorrhage. New York courts have accepted such claims under strict liability and negligence theories.

New York imposes a three-year statute of limitations for personal injury claims under CPLR §214, which generally runs from the date of injury or the date you discovered—or reasonably should have discovered—the connection between Eliquis and your bleeding event. If your injury involved a death, the wrongful death deadline is two years from the date of passing under EPTL §5-4.1. Missing these deadlines bars your claim permanently, so consult an attorney immediately.

In a successful New York product liability case, you may recover compensation for medical expenses, lost wages, pain and suffering, and permanent disability caused by the internal bleeding event. New York does not cap compensatory damages in most personal injury cases, but each case turns on its own facts and severity of harm. No specific recovery amount is guaranteed.

Most Eliquis bleeding cases are filed as individual lawsuits rather than class actions, because the injuries and damages vary significantly from person to person. Many cases have been coordinated in federal multidistrict litigation (MDL) and in state court proceedings. A New York personal injury attorney can evaluate whether your case is best pursued individually or as part of coordinated litigation.